1-94078579-AC-ACC

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_000350.3(ABCA4):​c.1356+10dupG variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.684 in 1,125,016 control chromosomes in the GnomAD database, including 293,115 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.73 ( 37420 hom., cov: 0)
Exomes 𝑓: 0.68 ( 255695 hom. )

Consequence

ABCA4
NM_000350.3 intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -1.16

Publications

2 publications found
Variant links:
Genes affected
ABCA4 (HGNC:34): (ATP binding cassette subfamily A member 4) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This protein is a retina-specific ABC transporter with N-retinylidene-PE as a substrate. It is expressed exclusively in retina photoreceptor cells, and the gene product mediates transport of an essental molecule, all-trans-retinal aldehyde (atRAL), across the photoreceptor cell membrane. Mutations in this gene are found in patients diagnosed with Stargardt disease, a form of juvenile-onset macular degeneration. Mutations in this gene are also associated with retinitis pigmentosa-19, cone-rod dystrophy type 3, early-onset severe retinal dystrophy, fundus flavimaculatus, and macular degeneration age-related 2. [provided by RefSeq, Sep 2019]
ABCA4 Gene-Disease associations (from GenCC):
  • ABCA4-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • cone-rod dystrophy 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • severe early-childhood-onset retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • retinitis pigmentosa 19
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Stargardt disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 1-94078579-A-AC is Benign according to our data. Variant chr1-94078579-A-AC is described in ClinVar as Benign. ClinVar VariationId is 193579.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.805 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000350.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABCA4
NM_000350.3
MANE Select
c.1356+10dupG
intron
N/ANP_000341.2
ABCA4
NM_001425324.1
c.1356+10dupG
intron
N/ANP_001412253.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABCA4
ENST00000370225.4
TSL:1 MANE Select
c.1356+10_1356+11insG
intron
N/AENSP00000359245.3
ABCA4
ENST00000649773.1
c.1356+10_1356+11insG
intron
N/AENSP00000496882.1

Frequencies

GnomAD3 genomes
AF:
0.726
AC:
101824
AN:
140250
Hom.:
37396
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.621
Gnomad AMI
AF:
0.819
Gnomad AMR
AF:
0.786
Gnomad ASJ
AF:
0.785
Gnomad EAS
AF:
0.828
Gnomad SAS
AF:
0.675
Gnomad FIN
AF:
0.698
Gnomad MID
AF:
0.586
Gnomad NFE
AF:
0.768
Gnomad OTH
AF:
0.723
GnomAD2 exomes
AF:
0.743
AC:
183870
AN:
247414
AF XY:
0.738
show subpopulations
Gnomad AFR exome
AF:
0.621
Gnomad AMR exome
AF:
0.783
Gnomad ASJ exome
AF:
0.781
Gnomad EAS exome
AF:
0.815
Gnomad FIN exome
AF:
0.708
Gnomad NFE exome
AF:
0.764
Gnomad OTH exome
AF:
0.759
GnomAD4 exome
AF:
0.678
AC:
668025
AN:
984656
Hom.:
255695
Cov.:
22
AF XY:
0.680
AC XY:
345921
AN XY:
508446
show subpopulations
African (AFR)
AF:
0.540
AC:
13682
AN:
25328
American (AMR)
AF:
0.772
AC:
33097
AN:
42884
Ashkenazi Jewish (ASJ)
AF:
0.757
AC:
16874
AN:
22292
East Asian (EAS)
AF:
0.822
AC:
28915
AN:
35182
South Asian (SAS)
AF:
0.606
AC:
46739
AN:
77112
European-Finnish (FIN)
AF:
0.699
AC:
35146
AN:
50294
Middle Eastern (MID)
AF:
0.584
AC:
2780
AN:
4758
European-Non Finnish (NFE)
AF:
0.674
AC:
460683
AN:
683182
Other (OTH)
AF:
0.690
AC:
30109
AN:
43624
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
6903
13805
20708
27610
34513
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7964
15928
23892
31856
39820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.726
AC:
101899
AN:
140360
Hom.:
37420
Cov.:
0
AF XY:
0.724
AC XY:
48772
AN XY:
67406
show subpopulations
African (AFR)
AF:
0.622
AC:
22991
AN:
36988
American (AMR)
AF:
0.786
AC:
10663
AN:
13566
Ashkenazi Jewish (ASJ)
AF:
0.785
AC:
2658
AN:
3388
East Asian (EAS)
AF:
0.827
AC:
3838
AN:
4642
South Asian (SAS)
AF:
0.676
AC:
2878
AN:
4260
European-Finnish (FIN)
AF:
0.698
AC:
5862
AN:
8404
Middle Eastern (MID)
AF:
0.585
AC:
166
AN:
284
European-Non Finnish (NFE)
AF:
0.768
AC:
50748
AN:
66056
Other (OTH)
AF:
0.726
AC:
1368
AN:
1884
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
1222
2444
3665
4887
6109
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
786
1572
2358
3144
3930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.726
Hom.:
5838
Asia WGS
AF:
0.787
AC:
2733
AN:
3470

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 19, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Retinitis Pigmentosa, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Stargardt Disease, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Cone-Rod Dystrophy, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Macular degeneration Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs281865386; hg19: chr1-94544135; API